Corinne John

Dr. Corinne John is co-founder, Executive Vice President and board member of Redbiotec AG. She is responsible for Human Resources and IP Strategy. Corinne was a member of the core M&A team leading Redbiotec to its first exit deal: Spin-off Redvax sold to Pfizer. Corinne obtained her PhD in the field of biochemistry from ETH Zürich and performed research at Harvard Medical School in Boston, USA. She holds a M.Sc. in Biotechnology from ESBS, France, and a technology entrepreneurship degree from the executive school of HSG.